The intestinal flora, composed of a diverse community of bacteria, plays an essential role in our overall health. Recently, researchers have done a lot of research to understand how these gut microorganisms can influence certain diseases, such as heart disease.
now, A study published in the journal Cellwho analyzed the composition of the gut microbiota of 1,429 participants and linked it to cardiovascular risk factors and heart complications, reached important conclusions.
The results revealed that some bacterial species are associated with lower cholesterol levels. More specifically, researchers realized that the probiotic bacteria Oscillibacter had been identified as “cholesterol-eating,” suggesting that these organisms have a protective role against heart disease.
Oscillibacter bacteria convert cholesterol into intermediate products that serve as food for other bacteria, which break down these byproducts and facilitate their elimination from the body.
As El Español newspaper, which highlights this study, explains, there is another type of intestinal bacteria, Eubacterium coprostanoligenes, which also contributes to lowering cholesterol levels. This type carries a gene that is actually linked to cholesterol metabolism. If Eubacterium joins Oscillibacter, a synergistic effect occurs between both bacteria, enhancing their effect on cholesterol degradation.
Understanding these interactions between gut microbiota and heart disease could lead to new strategies for preventing and treating cardiovascular disease. Research continues to uncover the secrets of these microbial communities and their impact on our health.
Emily Brontë is a journalist and feature writer specialising in culture, entertainment, literature, and current affairs. She is dedicated to producing clear, accurate reporting that helps readers stay informed about developments in the UK and around the world.
